Drapac Technology

Drapac invests extensively in developing the Drapac® pipeline of health-promoting products made from natural raw materials. These innovative products represent Drapac’s unique Intellectual Property. To support Drapac’s own innovation capability, the company is hosting world-class scientists to carry out research and product development in collaboration with universities and research institutes in New Zealand and overseas. We thank all New Zealand tax payers for significant amount of New Zealand Government Funding supporting Drapac Research and Development.

Quality policy & Development

science2.jpg

Drapac pipeline products are made in world-class manufacturing facilities with premium quality ingredients. Drapac guarantees the quality of all Drapac products.


Drapac invests extensively in developing the Drapac® pipeline of health-promoting products made from natural raw materials. These innovative products represent Drapac’s unique Intellectual Property. To support Drapac’s own innovation capability, the company is hosting world-class scientists to carry out research and product development in collaboration with universities and research institutes in New Zealand and overseas. We thank all New Zealand taxpayers for a significant amount of New Zealand Government Funding supporting Drapac Research and Development.

PUBLICATIONS RELATED TO DRAPAC PRODUCTS

Bian, L., Molan, A. L., Maddox, I., & Shu, Q. (2011). Antimicrobial a ctivity of Lactobacillus reuteri DPC16 supernatants against selected food borne pathogens. World Journal of Microbiology & Biotechnol ogy, 27(4), 991-998.

Chen S. (2007) Modeling the Cellular Integrity of Microencapsulated and Freeze-dried L. reuteri DPC16 and Optimizing Processing Fac tors for Longer Shelf-life Master Thesis, Medical and Health Scienc e, University of Auckland, Auckland, New Zealand

Bian L. (2008) An in vitro antimicrobial and safety study of Lactobac illus reuteri DPC16 for validation of probiotic concept. Masters Thes is, School of Engineering and Advanced Technology, Massey Unive rsity, Auckland, New Zealand

Lu, G. (2007). A novel approach for controlling foodborne pathogen s using modified atmosphere and Lactobacillus reuteri DPC16. PhD of Food Science Thesis. Massey University, Auckland, New Zealand.

Bian, L. (2008). An in vitro antimicrobial and safety study of Lactoba cillus reuteri DPC16 for validation of probiotic concept. Master of Sc ience Thesis. Massey University, Auckland, New Zealand.

Tian, H., Maddox, I., Ferguson, L., & Shu, Q. (2010). Influence of bo vine lactoferrin on selected probiotic bacteria and intestinal pathoge ns. Biometals, 23(3), 593-596. 

Chen S, Ferguson LR, Shu Q, Garg S. The application of flow cyto metry to the characterisation of a probiotic strain Lactobacillus reut eri DPC16 and the evaluation of sugar preservatives for its lyophiliz ation. LWT - Food Science and Technology. 2011;44:1873-9. [doi: 10.1016/j.lwt.2011.05.006] 

Liu A., Duan E., Duan Y., Chen S., Wu J., Shi X., Nagarwala A., Jos hi M., Gao Y.H., Chen X.D. & Shu Q. (2004c) Health-promoting pro perties of Probiopolis: Reduces the severity of Salmonella typhymur ium infection in mice. Paper presented at the Microbes Outside the Square, Palmerston North, New Zealand. 

Chen S, Zhao Q, Ferguson LR, Shu Q, Weir I, Garg S. Development of a novel probiotic delivery system based on microencapsulation wi th protectants. Applied Microbiology and Biotechnology. 2012;93:14 47-57. [doi:10.1007/s00253-011-3609-4]

Zhao, Q., Mutukumira, A. N., Lee, S. J., Maddox, I., & Shu, Q.(2011) Functional properties of free and encapsulated Lactobacillus reuteri DPC16 during and after passage through a simulated gastrointestin al tract. World Journal of Microbiology and Biotechnology, doi:10.10 07/s11274-011-0792-5. 

Chen S, Cao Y, Ferguson LR, Shu Q, Garg S. Flow cytometric asse ssment of the protectants for enhanced in vitro survival of probiotic lactic acid bacteria through simulated human gastro-intestinal stres ses. Applied Microbiology and Biotechnology. 2012;95:345-56. [do i: 10.1007/s00253-012-4030-3] 

Liu A., Duan E., Duan Y., Chen S., Wu J., Shi X., Nagarwala A., Jos hi M., Gao Y.H., Chen X.D. & Shu Q. (2004b) Health-promoting pro perties of Probiocaps: Enhances resistance to Rotavirus Infection i n mouse and piglet models. Paper presented at the Microbes Outsi de the Square, Palmerston North, New Zealand. 

Chen S, Cao Y, Ferguson LR, Shu Q, Garg S. The effect of immobil ization of probiotic Lactobacillus reuteri DPC16 in sub-100 μm mic rocapsule on food-borne pathogens. World Journal of Microbiology and Biotechnology. 2012;28:2447-52. [doi: 10.1007/s11274-012- 1046-x]

Tian H., Maddox I.S., Ferguson L.R. & Shu Q. (2010a) Evaluation o f the cytoprotective effects of bovine lactoferrin against intestinal tox ins using cellular model systems. Biometals 23, 589-92. Bibliograph y 181. 

Chen S, Cao Y, Ferguson LR, Shu Q, Garg S. Evaluation of mucoa dhesive coatings of chitosan and thiolated chitosan for the colonic d elivery of microencapsulated probiotic bacteria. 2012; Epub ahead of print. [doi: 10.3109/02652048.。。]

Tian H., Maddox I.S., Ferguson L.R. & Shu Q. (2010b) Influence of bovine lactoferrin on selected probiotic bacteria and intestinal patho gens. Biometals 23, 593-6. 

Chen S, Shu Q, Liu A, Riddle P, Ferguson LR, Garg S. Modelling th e cellular integrity of microencapsulated and lyophilised Lactobacillu s reuteri DPC16 and optimising processing parameters for enhance d cell viability. HealtheX 2008 Conference. 12th September 2008, Auckland, New Zealand.

Zhao Q., Lee S.J., Mutukumira A.N., Maddox I. & Shu Q. (2011) Via bility and delivery of immobilised Lactobacillus reuteri DPC16 within calcium alginate gel systems during sequential passage through si mulated gastrointestinal fluids. Benef Microbes 2, 129-38. 

Chen S, Tian H, Ferguson LR, Shu Q, Garg S. Characterisation of a novel probiotic strain – Lactobacillus reuteri DPC16. APSA 2008 C onference. 6th-9th December 2008, Canberra, Australia. 

Shu Q. & Liu A. (2008) Lactobacillus reuteri DPC16. N.Z. Patent No 526544. New Zealand Intellectual Property Database Extract, New Zealand Intellectual Property Office. 

Chen S, Ferguson LR, Garg S, Shu Q. Application of flow cytometry to the characterisation of stress resistance of the probiotic strain La ctobacillus reuteri DPC16 and evaluation of sugars as preservative for this strain to survive lyophilisation. NZBIO Conference 2010. 22 nd-24th March 2010, Auckland, New Zealand. 

Liu A., Chen S., Duan E., Wu J., Shi X., Nagarwala A., Joshi M., Ga o Y.H., Chen X.D. & Shu Q. (2004a) Health-promoting properties o f probiotics-colostrums: Enhances non-specific and specific immun e responses in mice challenged with Escherichia coli O157:H7. Paper presented at the Microbes Outside the Square, Palmerston North New Zealand. Bibliography 172